Download Files:
Products Details
Product Description
– SSTR4 agonist 2 is a potent agonist of somatostatin receptor subtype 4 (SSTR4). SSTR4 pathway inhibits nociceptive and inflammatory processes. SSTR4 agonist 2 has the potential for the research of medical disorders related to SSTR4 (extracted from patent WO2014184275A1, compound 107)[1].
Web ID
– HY-142699
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C18H24N4O
References
– [1]Riccardo Giovannini, et al. New somatostatin receptor subtype 4 (sstr4) agonists. Patent WO2014184275A1.
CAS Number
– 1638589-52-2
Molecular Weight
– 312.41
SMILES
– CC(C)(C(C1=CC=C2)=NN(C)C1=C2C)NC([C@H]3[C@@]4([H])[C@]3([H])CNC4)=O
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– Somatostatin Receptor
Pathway
– GPCR/G Protein;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
